Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy
Clinical trial NCT01888575 · COMPLETED
Trial details
- NCT number
- NCT01888575
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-06-01
- Enrollment
- 35604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.